Works matching IS 11732563 AND DT 2021 AND VI 41 AND IP 4
Results: 10
Safety and Efficacy of Rivaroxaban and Apixaban in Patients with Increased Body Mass: a Systematic Review.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 4, p. 353, doi. 10.1007/s40261-021-01019-4
- By:
- Publication type:
- Article
Cost-effectiveness Analysis of Atezolizumab Plus Nab-Paclitaxel for Advanced PD-L1 Positive Triple-Negative Breast Cancer in Japan.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 4, p. 381, doi. 10.1007/s40261-021-01017-6
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Ropeginterferon Alfa-2b in Healthy Japanese and Caucasian Subjects After Single Subcutaneous Administration.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 4, p. 391, doi. 10.1007/s40261-021-01026-5
- By:
- Publication type:
- Article
Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 4, p. 293, doi. 10.1007/s40261-021-01020-x
- By:
- Publication type:
- Article
Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-Analysis.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 4, p. 341, doi. 10.1007/s40261-021-01016-7
- By:
- Publication type:
- Article
Correction to: The CITIMERIVA Study: CITIcoline plus MEmantine plus RIVAstigmine in Older Patients Affected with Alzheimer's Disease.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Cost-effectiveness of Empagliflozin Compared with Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Greece.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 4, p. 371, doi. 10.1007/s40261-021-01013-w
- By:
- Publication type:
- Article
Overall Efficacy and Safety of Safinamide in Parkinson's Disease: A Systematic Review and a Meta-analysis.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 4, p. 321, doi. 10.1007/s40261-021-01011-y
- By:
- Publication type:
- Article
Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 4, p. 405, doi. 10.1007/s40261-021-01010-z
- By:
- Publication type:
- Article
Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 4, p. 303, doi. 10.1007/s40261-021-01000-1
- By:
- Publication type:
- Article